tradingkey.logo


MiMedx Group Inc

MDXG
6.930USD
+0.070+1.02%
終倀 12/05, 16:00ET15分遅れの株䟡
1.03B時䟡総額
25.13盎近12ヶ月PER


詳现情報 MiMedx Group Inc 䌁業名

MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.

MiMedx Group Incの䌁業情報


䌁業コヌドMDXG
䌚瀟名MiMedx Group Inc
䞊堎日Aug 20, 2007
最高経営責任者「CEO」Mr. Joseph H. (Joe) Capper
埓業員数837
蚌刞皮類Ordinary Share
決算期末Aug 20
本瀟所圚地1775 W Oak Commons Court, Ne
郜垂MARIETTA
蚌刞取匕所NASDAQ Capital Market Consolidated
囜United States of America
郵䟿番号30062
電話番号17706519100
りェブサむトhttps://mimedx.com/
䌁業コヌドMDXG
䞊堎日Aug 20, 2007
最高経営責任者「CEO」Mr. Joseph H. (Joe) Capper

MiMedx Group Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
529.53K
+60.69%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
+15.53%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
190.25K
-57.15%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
+18.66%
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
+98.69%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
30.74K
-65.48%
Mr. William A. (Bill) Hawkins, III
Mr. William A. (Bill) Hawkins, III
Independent Director
Independent Director
--
--
Mr. Douglas C. Rice
Mr. Douglas C. Rice
Chief Financial Officer
Chief Financial Officer
--
--
Mr. K. Todd Newton
Mr. K. Todd Newton
Independent Director
Independent Director
--
--
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
529.53K
+60.69%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
+15.53%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
190.25K
-57.15%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
+18.66%
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
+98.69%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
30.74K
-65.48%

収益内蚳

通貚: USD曎新時刻: Mon, Oct 6
通貚: USD曎新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
事業別USD
䌚瀟名
収益
比率
Advanced Wound Care
64.48M
65.39%
Surgical
34.13M
34.61%
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Advanced Wound Care
64.48M
65.39%
Surgical
34.13M
34.61%

株䞻

曎新時刻: Sun, Nov 16
曎新時刻: Sun, Nov 16
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
EW Healthcare Partners
19.04%
BlackRock Institutional Trust Company, N.A.
5.90%
Trigran Investments, Inc.
5.20%
The Vanguard Group, Inc.
4.58%
First Light Asset Management, LLC
2.47%
他の
62.82%
株䞻統蚈
株䞻統蚈
比率
EW Healthcare Partners
19.04%
BlackRock Institutional Trust Company, N.A.
5.90%
Trigran Investments, Inc.
5.20%
The Vanguard Group, Inc.
4.58%
First Light Asset Management, LLC
2.47%
他の
62.82%
皮類
株䞻統蚈
比率
Investment Advisor
19.22%
Venture Capital
19.04%
Investment Advisor/Hedge Fund
18.75%
Hedge Fund
11.78%
Research Firm
2.14%
Individual Investor
1.79%
Pension Fund
0.62%
Bank and Trust
0.36%
Insurance Company
0.03%
他の
26.28%

機関投資家保有株


曎新時刻: Wed, Oct 1
曎新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q3
443
104.90M
70.83%
-3.83M
2025Q2
451
106.45M
71.95%
-3.98M
2025Q1
460
106.92M
72.40%
-5.30M
2024Q4
455
107.57M
73.21%
-3.01M
2024Q3
429
103.18M
70.48%
-6.90M
2024Q2
424
100.59M
68.44%
-3.52M
2024Q1
405
106.53M
74.65%
+1.42M
2023Q4
391
100.91M
86.85%
+27.80M
2023Q3
385
72.00M
62.20%
-22.83M
2023Q2
375
65.55M
56.85%
-21.21M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
EW Healthcare Partners
28.20M
19.06%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
8.81M
5.95%
+232.31K
+2.71%
Jun 30, 2025
Trigran Investments, Inc.
8.39M
5.67%
+790.90K
+10.41%
Jun 30, 2025
The Vanguard Group, Inc.
6.93M
4.69%
+246.16K
+3.68%
Jun 30, 2025
First Light Asset Management, LLC
1.93M
1.3%
-1.53M
-44.18%
Jun 30, 2025
State Street Investment Management (US)
3.47M
2.34%
+5.97K
+0.17%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.84M
1.92%
-69.37K
-2.38%
Jun 30, 2025
Paradigm Capital Management, Inc.
4.45M
3.01%
-231.10K
-4.93%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
2.28M
1.54%
+274.09K
+13.64%
Jun 30, 2025
Cannell Capital, LLC
2.07M
1.4%
-59.03K
-2.77%
Jun 30, 2025
詳现を芋る

関連ETF


曎新時刻: Tue, Dec 2
曎新時刻: Tue, Dec 2
銘柄名
比率
Invesco NASDAQ Future Gen 200 ETF
0.58%
Janus Henderson Small Cap Growth Alpha ETF
0.56%
First Trust Small Cap Growth AlphaDEX Fund
0.3%
iShares Micro-Cap ETF
0.17%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.16%
Franklin US Small Cap Multifactor Index ETF
0.15%
Vanguard US Quality Factor ETF
0.14%
WisdomTree US SmallCap Quality Growth Fund
0.14%
VictoryShares Small Cap Free Cash Flow ETF
0.12%
State Street SPDR S&P Biotech ETF
0.12%
詳现を芋る
Invesco NASDAQ Future Gen 200 ETF
比率0.58%
Janus Henderson Small Cap Growth Alpha ETF
比率0.56%
First Trust Small Cap Growth AlphaDEX Fund
比率0.3%
iShares Micro-Cap ETF
比率0.17%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.16%
Franklin US Small Cap Multifactor Index ETF
比率0.15%
Vanguard US Quality Factor ETF
比率0.14%
WisdomTree US SmallCap Quality Growth Fund
比率0.14%
VictoryShares Small Cap Free Cash Flow ETF
比率0.12%
State Street SPDR S&P Biotech ETF
比率0.12%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
皮類
比率
デヌタなし
日付
皮類
比率
デヌタなし

よくある質問

MiMedx Group Incの䞊䜍5名の株䞻は誰ですか


MiMedx Group Incの䞊䜍5名の株䞻は以䞋のずおりです。
EW Healthcare Partnersは28.20M株を保有しおおり、これは党䜓の19.06%に盞圓したす。
BlackRock Institutional Trust Company, N.A.は8.81M株を保有しおおり、これは党䜓の5.95%に盞圓したす。
Trigran Investments, Inc.は8.39M株を保有しおおり、これは党䜓の5.67%に盞圓したす。
The Vanguard Group, Inc.は6.93M株を保有しおおり、これは党䜓の4.69%に盞圓したす。
First Light Asset Management, LLCは1.93M株を保有しおおり、これは党䜓の1.30%に盞圓したす。

MiMedx Group Incの株䞻タむプ䞊䜍3皮は䜕ですか


MiMedx Group Incの株䞻タむプ䞊䜍3皮は、
EW Healthcare Partners
BlackRock Institutional Trust Company, N.A.
Trigran Investments, Inc.

MiMedx Group IncMDXGの株匏を保有しおいる機関の数はいく぀ですか


2025Q3時点で、MiMedx Group Incの株匏を保有しおいる機関は443瀟あり、保有株匏の総垂堎䟡倀は玄104.90Mで、党䜓の70.83%を占めおいたす。2025Q2ず比范しお、機関の持ち株は-1.12%増加しおいたす。

MiMedx Group Incの最倧の収益源は䜕ですか


FY2025Q2においお、Advanced Wound Care郚門がMiMedx Group Incにずっお最倧の収益を生み出しおおり、その金額は64.48Mで、党収益の65.39%を占めおいたす。
KeyAI
î™